VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ISA 2022 | Rationale for anti-amyloid therapy in systemic amyloidosis

Marina Ramirez-Alvarado, PhD, Mayo Clinic, Rochester, MN, outlines the kinetic and thermodynamic rationale for anti-amyloid therapy in systemic amyloidosis. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.

Disclosures

Honorarium from Attralus

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter